Infection and Cancer Program, Abteilung F010 and Inserm U701, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.
J Oncol. 2011;2011:741868. doi: 10.1155/2011/741868. Epub 2011 Jul 12.
Accumulating evidence suggests an important role for cyclooxygenase-2 (COX-2) in the pathogenesis of a wide range of malignancies. The protumorigenic properties of COX-2 are generally thought to be mediated by its product, PGE(2), which is shown to promote tumor spread and growth by multiple mechanisms but most importantly through modulation of the local immune response in the tumor. Pancreatic tumor cells produce various amounts of PGE(2), some of them being even deficient in COX enzymes or other PGE(2) synthases. Here we describe that, beside pancreatic tumor cells or stromal fibroblasts, human peripheral blood mononuclear cells can also produce PGE(2) upon coculture with pancreatic cancer cells. Stimulating of cellular cPLA2 within PBMCs by secreted factors, presumably sPLA2, from tumor cells appeared crucial, while the direct contact between PBMCs and PDACs seemed to be dispensable for this effect. Our data is emphasizing the complex interactions participating in the formation of the tolerogenic immune milieu within pancreatic tumors.
越来越多的证据表明环氧化酶-2(COX-2)在多种恶性肿瘤的发病机制中起着重要作用。COX-2 的促肿瘤特性通常被认为是由其产物 PGE(2)介导的,PGE(2)通过多种机制促进肿瘤的扩散和生长,但最重要的是通过调节肿瘤局部免疫反应。胰腺肿瘤细胞产生各种量的 PGE(2),其中一些甚至缺乏 COX 酶或其他 PGE(2)合酶。在这里,我们描述了除胰腺肿瘤细胞或基质成纤维细胞外,人外周血单核细胞在与胰腺癌细胞共培养时也可以产生 PGE(2)。肿瘤细胞分泌的因子(推测是 sPLA2)刺激 PBMC 内的细胞 cPLA2 似乎至关重要,而 PBMC 与 PDAC 之间的直接接触对于这种效应似乎是可有可无的。我们的数据强调了参与形成胰腺肿瘤内耐受免疫环境的复杂相互作用。